The LIBERATE tibolone trial in breast cancer survivors.
作者信息
Speroff Leon
出版信息
Maturitas. 2009 May 20;63(1):1-3. doi: 10.1016/j.maturitas.2009.03.001. Epub 2009 Mar 26.
Abstract
摘要
相似文献
1
The LIBERATE tibolone trial in breast cancer survivors.
Maturitas. 2009 May 20;63(1):1-3. doi: 10.1016/j.maturitas.2009.03.001. Epub 2009 Mar 26.
2
Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Gynecol Endocrinol. 2010 Nov;26(11):804-14. doi: 10.3109/09513590.2010.495437.
3
Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
Gynecol Endocrinol. 2010 Apr;26(4):237-9. doi: 10.3109/09513590903507339.
4
[Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
Duodecim. 2011;127(3):235-42.
5
Progestins and recurrence in breast cancer survivors.
J Natl Cancer Inst. 2005 Apr 6;97(7):471-2. doi: 10.1093/jnci/dji100.
6
What have we really learned from 'LIBERATE' trial?
Maturitas. 2010 May;66(1):99-100. doi: 10.1016/j.maturitas.2010.02.012. Epub 2010 Mar 16.
7
Tibolone and breast cancer risk: effects of selection bias cannot be eliminated in observational studies.
BJOG. 2008 Jun;115(7):919. doi: 10.1111/j.1471-0528.2008.01735.x.
8
A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
J Obstet Gynaecol. 2007 May;27(4):433-4. doi: 10.1080/01443610701362914.
9
Some comments on the Million Women Study.
Climacteric. 2003 Dec;6(4):357.
10
Tibolone: the way to beat many a postmenopausal ailments.
Expert Opin Pharmacother. 2008 Apr;9(6):1039-47. doi: 10.1517/14656566.9.6.1039.
引用本文的文献
1
Menopausal Hormone Therapy in Breast Cancer Survivors.
Cancers (Basel). 2024 Sep 26;16(19):3267. doi: 10.3390/cancers16193267.
Zotero 插件